• Chiral Nanomaterials: Design and engineering of chiral inorganic nanoparticles for antibacterial surfaces and high-sensitivity biomolecule detection.

• Extracellular Vesicles (EVs): Development of advanced methods for capturing and fingerprinting extracellular vesicles as precision disease biomarkers.

• AI in Nanobiotechnology: Utilizing deep learning and machine learning models to analyze and predict nanoparticle-microbe interactions.

• Biomimetic Systems: Designing biomimetic inorganic nanostructures for efficient drug and DNA delivery systems.

Research Area: Nano–Bio Interfaces and Inorganic Nanoparticles Laboratory (ESTE Lab) focuses on the design, synthesis, and characterization of inorganic nanoparticles (with a particular emphasis on chiral nanostructures) for biomedical applications, including strategies against antibiotic-resistant pathogens and improved drug delivery platforms. The laboratory also develops methods for capturing, isolating, and analyzing extracellular vesicles (EVs) to support biomarker discovery and diagnostic applications. Nanoparticle interactions with proteins, EVs, and cells are investigated using SEM, TEM, Raman spectroscopy, and LC-MS–based analyses.